104 related articles for article (PubMed ID: 2989389)
1. In vivo antiviral activity of recombinant murine gamma interferon.
Shalaby MR; Hamilton EB; Benninger AH; Marafino BJ
J Interferon Res; 1985; 5(2):339-45. PubMed ID: 2989389
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of orally/sublingually, intranasally, and intraperitoneally administered recombinant murine interferon in the treatment of murine encephalomyocarditis virus.
Sonnenfeld G; Tovey M; Schellekens H; Kinney KS; Belay T; Morton DS; Austin CE; Reitman M; Fong TA; Vaughan HS
J Interferon Cytokine Res; 2001 Jul; 21(7):539-45. PubMed ID: 11506749
[TBL] [Abstract][Full Text] [Related]
3. The gamma interferon (IFN-gamma) mimetic peptide IFN-gamma (95-133) prevents encephalomyocarditis virus infection both in tissue culture and in mice.
Mujtaba MG; Patel CB; Patel RA; Flowers LO; Burkhart MA; Waiboci LW; Martin J; Haider MI; Ahmed CM; Johnson HM
Clin Vaccine Immunol; 2006 Aug; 13(8):944-52. PubMed ID: 16893996
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of different mouse interferons in mice infected with encephalomyocarditis (EMC).
LobodziĆska M; Albin M
Arch Immunol Ther Exp (Warsz); 1982; 30(1-2):49-55. PubMed ID: 6184029
[TBL] [Abstract][Full Text] [Related]
5. [Action of human leukocyte and immune interferons on the reproduction and cytopathogenic effect of the encephalomyocarditis virus in mice].
Mentkevich LM; Zhdanova LV; Meshkova EN
Vopr Virusol; 1984; 29(5):582-5. PubMed ID: 6097046
[TBL] [Abstract][Full Text] [Related]
6. The in vivo antiviral activity of interleukin-12 is mediated by gamma interferon.
Ozmen L; Aguet M; Trinchieri G; Garotta G
J Virol; 1995 Dec; 69(12):8147-50. PubMed ID: 7494339
[TBL] [Abstract][Full Text] [Related]
7. Regulation of macrophage growth and antiviral activity by interferon-gamma.
Goldberg M; Belkowski LS; Bloom BR
J Cell Biol; 1989 Sep; 109(3):1331-40. PubMed ID: 2549078
[TBL] [Abstract][Full Text] [Related]
8. Synergistic activities of type I (alpha, beta) and type II (gamma) murine interferons.
Zerial A; Hovanessian AG; Stefanos S; Huygen K; Werner GH; Falcoff E
Antiviral Res; 1982 Sep; 2(4):227-39. PubMed ID: 6293377
[TBL] [Abstract][Full Text] [Related]
9. Antiviral activity of limitin against encephalomyocarditis virus, herpes simplex virus, and mouse hepatitis virus: diverse requirements by limitin and alpha interferon for interferon regulatory factor 1.
Kawamoto S; Oritani K; Asada H; Takahashi I; Ishikawa J; Yoshida H; Yamada M; Ishida N; Ujiie H; Masaie H; Tomiyama Y; Matsuzawa Y
J Virol; 2003 Sep; 77(17):9622-31. PubMed ID: 12915574
[TBL] [Abstract][Full Text] [Related]
10. Oromucosal interferon therapy: relationship between antiviral activity and viral load.
Schellekens H; Geelen G; Meritet JF; Maury C; Tovey MG
J Interferon Cytokine Res; 2001 Aug; 21(8):575-81. PubMed ID: 11559435
[TBL] [Abstract][Full Text] [Related]
11. EMC virus infection in baboons as a model for studies on antiviral substances.
Levin R; Yaari A; Gitelman J; Bino T; Rosenberg H; Kohn A
Antiviral Res; 1986 Aug; 6(5):277-83. PubMed ID: 3021054
[TBL] [Abstract][Full Text] [Related]
12. Recombinant interferons alpha and gamma: comparative antiviral activity and synergistic interaction in encephalomyocarditis virus infection of mice.
Sim IS; Cerruti RL
Antiviral Res; 1987 Nov; 8(4):209-21. PubMed ID: 3128162
[TBL] [Abstract][Full Text] [Related]
13. Potentiating effect of murine interferon-gamma-containing lymphokine preparations on the antiviral and antiproliferative effects of murine interferon-alpha/beta: identification of the potentiation factor as murine interferon-gamma itself.
Fleischmann WR; Fleischmann CM
Antiviral Res; 1984 Aug; 4(4):221-8. PubMed ID: 6091541
[TBL] [Abstract][Full Text] [Related]
14. Circadian dependence of interferon antitumor activity in mice.
Koren S; Whorton EB; Fleischmann WR
J Natl Cancer Inst; 1993 Dec; 85(23):1927-32. PubMed ID: 8230283
[TBL] [Abstract][Full Text] [Related]
15. Peptide mimetics of gamma interferon possess antiviral properties against vaccinia virus and other viruses in the presence of poxvirus B8R protein.
Ahmed CM; Burkhart MA; Subramaniam PS; Mujtaba MG; Johnson HM
J Virol; 2005 May; 79(9):5632-9. PubMed ID: 15827178
[TBL] [Abstract][Full Text] [Related]
16. Effects of intranasal administration of recombinant murine interferon-gamma on murine acute myocarditis caused by encephalomyocarditis virus.
Yamamoto N; Shibamori M; Ogura M; Seko Y; Kikuchi M
Circulation; 1998 Mar; 97(10):1017-23. PubMed ID: 9529271
[TBL] [Abstract][Full Text] [Related]
17. Tumour necrosis factor-alpha, interferon-gamma and interferon-beta exert antiviral activity in nervous tissue cells.
Schijns VE; Van der Neut R; Haagmans BL; Bar DR; Schellekens H; Horzinek MC
J Gen Virol; 1991 Apr; 72 ( Pt 4)():809-15. PubMed ID: 1849968
[TBL] [Abstract][Full Text] [Related]
18. The interaction of interferon-alpha and -gamma: regulation of (2-5)A synthetase activity.
Fish EN; Hannigan GE; Banerjee K; Williams BR
Virology; 1988 Jul; 165(1):87-94. PubMed ID: 2455384
[TBL] [Abstract][Full Text] [Related]
19. Recombinant murine gamma interferon induces enhanced resistance to Listeria monocytogenes infection in neonatal mice.
Chen Y; Nakane A; Minagawa T
Infect Immun; 1989 Aug; 57(8):2345-9. PubMed ID: 2501217
[TBL] [Abstract][Full Text] [Related]
20. Disparate response of encephalomyocarditis virus and MM virus to interferon in JLS-V9R cells.
Czarniecki CW; Allen PT
Antiviral Res; 1984 Dec; 4(6):351-5. PubMed ID: 6099710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]